Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis
- PMID: 19006645
- DOI: 10.1016/j.canlet.2008.09.023
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis
Abstract
Artemisinin, a natural product isolated from Artemisia annua, contains an endoperoxide group that can be activated by intracellular iron to generate toxic radical species. Cancer cells over-express transferrin receptors (TfR) for iron uptake while most normal cells express nearly undetectable levels of TfR. We prepared a series of artemisinin-tagged transferrins (ART-Tf) where different numbers of artemisinin units are attached to the N-glycoside chains of transferrin (Tf). The Tf bearing approximately 16 artemisinins retains the functionality of both Tf and artemisinin. Reduction of TfRs by TfR siRNA transfection significantly impaired the ability of ART-Tf, but not dihydroartemisinin, to kill cells. We also demonstrate that the ART-Tf conjugate kills the prostate carcinoma cell line DU 145 by the mitochondrial pathway of apoptosis.
Similar articles
-
Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide.Cancer Lett. 2009 Feb 8;274(1):33-9. doi: 10.1016/j.canlet.2008.08.031. Epub 2008 Oct 5. Cancer Lett. 2009. PMID: 18838215
-
Effects of artemisinin-tagged holotransferrin on cancer cells.Life Sci. 2005 Jan 28;76(11):1267-79. doi: 10.1016/j.lfs.2004.08.020. Epub 2004 Nov 23. Life Sci. 2005. PMID: 15642597
-
Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells.Anticancer Drugs. 2010 Apr;21(4):423-32. doi: 10.1097/CAD.0b013e328336f57b. Anticancer Drugs. 2010. PMID: 20130467 Free PMC article.
-
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.Clin Immunol. 2006 Nov;121(2):144-58. doi: 10.1016/j.clim.2006.06.010. Epub 2006 Aug 10. Clin Immunol. 2006. PMID: 16904380 Review.
-
Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation.Int J Pharm. 2008 Apr 16;354(1-2):28-33. doi: 10.1016/j.ijpharm.2007.09.003. Epub 2007 Sep 6. Int J Pharm. 2008. PMID: 17942255 Review.
Cited by
-
Artemisinin and its derivatives: a promising cancer therapy.Mol Biol Rep. 2020 Aug;47(8):6321-6336. doi: 10.1007/s11033-020-05669-z. Epub 2020 Jul 24. Mol Biol Rep. 2020. PMID: 32710388 Review.
-
Self-assembled IR780-loaded transferrin nanoparticles as an imaging, targeting and PDT/PTT agent for cancer therapy.Sci Rep. 2016 Jun 6;6:27421. doi: 10.1038/srep27421. Sci Rep. 2016. PMID: 27263444 Free PMC article.
-
Dihydroartemisinin-Transferrin Adducts Enhance TRAIL-Induced Apoptosis in Triple-Negative Breast Cancer in a P53-Independent and ROS-Dependent Manner.Front Oncol. 2022 Jan 3;11:789336. doi: 10.3389/fonc.2021.789336. eCollection 2021. Front Oncol. 2022. PMID: 35047402 Free PMC article.
-
Experimental treatment of breast cancer-bearing BALB/c mice by artemisinin and transferrin-loaded magnetic nanoliposomes.Pharmacogn Mag. 2015 May;11(Suppl 1):S117-22. doi: 10.4103/0973-1296.157710. Pharmacogn Mag. 2015. PMID: 26109756 Free PMC article.
-
Molecular Basis of Prostate Cancer and Natural Products as Potential Chemotherapeutic and Chemopreventive Agents.Front Pharmacol. 2021 Sep 23;12:738235. doi: 10.3389/fphar.2021.738235. eCollection 2021. Front Pharmacol. 2021. PMID: 34630112 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous